About ProPhase Labs
ProPhase Labs is a publicly listed company based in Doylestown (United States) founded in 1989. Nutraceuticals and OTC health products are manufactured for disease remedies. The company has 96 employees. ProPhase Labs has completed 3 acquisitions, including Confucious Plaza Medical Laboratory Corporation, Nebula Genomics and VaccTrack. Its website prophaselabs.com draws about 10 thousand monthly visits. ProPhase Labs offers products and services including Whole Genome Sequencing, Cancer Diagnostic Test, and Health Supplements. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its legal entity is PROPHASE LABS, INC. Its competitors include ChromaDex, LifeVantage and Designs for Health; 1 of its 3 listed competitors has raised funding.
Company details
ProPhase Labs was founded in 1989 and is headquartered in Doylestown, United States. Operations focus on the nutraceuticals sector, where manufacturing of products for multiple diseases occurs alongside research and development of over-the-counter drugs and natural-based health items. Supplements, personal care, and cosmeceutical products are provided, including Cold-EEZE zinc gluconate lozenges, QuickMelts, gummies, oral sprays, organic cough drops, and vitamin C supplements.
- Headquarters Doylestown, United States
- Employees 96
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website prophaselabs.com
- Social LinkedIn Facebook
- Legal Name Prophase Labs, Inc.
- Annual Revenue$6.77 M (USD)-80.65as on Dec 31, 2024
- Net Profit-$53.36 M (USD)-217.98as on Dec 31, 2024
- EBITDA-$31.98 M (USD)-116.86as on Dec 31, 2024
- Latest Funding Round$3M (USD), Post-IPO
Jul 2025
- Investors
- Employee Count96
- Investments & Acquisitions
Products & Services of ProPhase Labs
ProPhase Labs offers a comprehensive portfolio of products and services, including Whole Genome Sequencing, Cancer Diagnostic Test, and Health Supplements.
Provides DNA sequencing for health insights and personalized medicine.
Detects esophageal cancer early through innovative testing methods.
Offers supplements for general health and wellness support.
Funding Insights of ProPhase Labs
- Total Rounds 5
- Last Round Post-IPO — $3M
- First Round $2.92M
(Mar 2010)
- Investors Count 1
All 5 funding rounds of ProPhase Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2025 | $3M | Post-IPO | – | – | – |
| Jun 2025 | $1M | Post-IPO | – | – | – |
| Dec 2015 | $1.5M | Post-IPO | – | – | – |
| Aug 2015 | Debt – Venture | – | – | ||
| Mar 2010 | $2.92M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in ProPhase Labs
ProPhase Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Altar Rock Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Altar Rock Capital operates as an investment management firm for clients. | 2019 | altarrockcapital.com | Boston, United States |
Investor details for ProPhase Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ProPhase Labs
10 people are tracked at ProPhase Labs (7 in leadership, 3 in team); the tracked headcount is 96.
| Name | Role | Group |
|---|---|---|
Monica Brady | Chief Financial Officer | Leadership |
Joseph Brennan | Sr VP Sales&marketing | Leadership |
Jason Karkus | President, DNA Complete | Leadership |
Igor Ban | Director Of Research Development | Leadership |
Sergio M. | Chief Information Officer | Leadership |
Ted Karkus | CEO And Chairman | Leadership |
Lance Bisesar | Head Of Finance | Leadership |
David Krumgalz | Data Analyst | Team |
Adam Moxon | Customer Account Manager | Team |
Alison Kovac | Controller | Team |
Complete people profiles for ProPhase Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ProPhase Labs
ProPhase Labs is a publicly listed company on the NASDAQ with ticker symbol PRPH in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Jan 1997
- Listed onNASDAQ: PRPH
- Listed entityProPhase Labs, Inc.
- Exchange sectorHealth technology
- ISINUS74345W1080
- Share price$0.36 (-18.97% on the day) · 2026-01-05
- Market capitalisation$2.2M
- Volume (last session)5,489,292
- Analyst consensusNeutral
Financials of ProPhase Labs
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $6.8M | -$53.4M | -$32.0M |
| 2023 | $35.0M | -$16.8M | -$14.8M |
| 2022 | $122.7M | $18.5M | $28.7M |
| 2021 | $79.0M | $6.3M | $14.7M |
| 2020 | $14.5M | -$2.3M | -$3.4M |
Detailed financial statements for ProPhase Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ProPhase Labs
ProPhase Labs has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Confucious Plaza Medical Laboratory Corporation, Nebula Genomics and VaccTrack.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
DNA sequencing technology for personal genomics is developed. | nebula.org | San Francisco, United States | 2016 | Aug 2021 | $14.6M | |
Cloud-based vaccination tracking is provided for patients and providers. | vacctrack.com | New York, United States | 2020 | Mar 2021 | •••• | |
Clinical laboratory and testing services are provided in New York. | cpmedicallab.org | New York, United States | 0 | Nov 2020 | •••• |
Complete acquisition details for ProPhase Labs
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ProPhase Labs
7 dated milestones of ProPhase Labs across 36 years, from founding to its latest funding, stage changes and deals.
- Founded ProPhase Labs is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $2.9M.
- Acquisition Acquires Confucious Plaza Medical Laboratory Corporation.
- Acquisition Acquires VaccTrack.
- Acquisition Acquires Nebula Genomics.
- Funding Latest funding round, Post-IPO, of $3.0M.
Competitors of ProPhase Labs
ProPhase Labs has 3 listed competitors in our database, 1 of them funded. They include ChromaDex, LifeVantage and Designs for Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromadex.com | 1999 | Irvine, United States | $3.35M | 228 | Nutritional ingredients for health and wellness are developed. | |
| lifevantage.com | 2003 | Monroe, United States | 248 | Nutritional products for various health ailments are provided. | ||
| designsforhealth.com | 1989 | Suffield, United States | 327 | Dietary supplements and medical foods are provided for health professionals. |
Detailed competitors of ProPhase Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProPhase Labs
The website of ProPhase Labs (prophaselabs.com) receives about 10.2K visits a month.
- Monthly visits10.2K
▲ 16.9% vs previous month
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as ProPhase Labs (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Prophase Labs
Complete news archive for ProPhase Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProPhase Labs
ProPhase Labs was founded in 1989 and raised its 1st funding round 21 years after it was founded.
ProPhase Labs is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.
ProPhase Labs has 96 employees.
Annual revenue of ProPhase Labs is $6.77M as on Dec 31, 2024.
ProPhase Labs was founded in 1989 and is headquartered in Doylestown, United States. Operations focus on the nutraceuticals sector, where manufacturing of products for multiple diseases occurs alongside research and development of over-the-counter drugs and natural-based health items. Supplements, personal care, and cosmeceutical products are provided, including Cold-EEZE zinc gluconate lozenges, QuickMelts, gummies, oral sprays, organic cough drops, and vitamin C supplements.
ProPhase Labs's top competitors include ChromaDex, LifeVantage and Designs for Health.
ProPhase Labs offers Whole Genome Sequencing, Cancer Diagnostic Test, and Health Supplements.
Yes, ProPhase Labs is publicly traded on NASDAQ under the ticker symbol PRPH.
ProPhase Labs has made 3 acquisitions, including Confucious Plaza Medical Laboratory Corporation, Nebula Genomics, and VaccTrack.
ProPhase Labs has 1 investor. Key investors include Altar Rock Capital.
ProPhase Labs operates through Prophase Labs, Inc..